Medicare Advantage Denies Post-Acute Care It Prepaid For
Medicare Advantage enrollees who leave the hospital needing skilled nursing or long-term acute care often meet the same obstacle: a denial letter. The plan was already paid a capitated rate to cover that benefit. The denial arrives anyway. This piece explains the machinery behind those letters, what the denials cost, and what a patient can do inside the appeals window.
Prepaid Care Meets Denial Letters
Medicare Advantage is a private insurance option that wraps around traditional Medicare, created under the Social Security Act of 1965 and administered today by the Centers for Medicare and Medicaid Services. Plans receive a fixed monthly payment per enrollee, adjusted for risk, rather than fee-for-service reimbursement. That capitation is the central fact of the programme. The plan keeps what it does not spend on care.
Post-acute care is a covered benefit under the programme. It includes skilled nursing facility stays, home health, inpatient rehabilitation, and long-term acute care hospital admissions. Enrollees pay premiums and cost-sharing in exchange for that coverage. The coverage is not discretionary on paper. In practice, it is filtered through utilization management before a dollar moves.
Denials typically arrive after discharge planning has started, sometimes on the day of transfer. A family that has toured a nursing home and arranged transport can receive a fax saying the stay is not medically necessary. The patient is still recovering. The appeal window is open, but the clock is short.
The Prior Authorization Machinery
Prior authorization is a utilization management process insurers use to decide whether a prescribed service will be covered. Medicare Advantage plans delegate much of this review to outside vendors. EviCore by Evernorth, owned by Cigna and based in Bluffton, South Carolina, is the largest such company in the United States, reviewing authorizations for more than a hundred insurers and Medicaid programmes.
Long-term acute care hospitals face particular scrutiny. These facilities specialize in patients who need extended hospitalization, and the modern LTACH category took shape after the Medicare, Medicaid, and SCHIP Balanced Budget Refinement Act of 1999 defined them by an average inpatient length of stay greater than 25 days. Every admission tends to require recertification, which means repeated reviews during a stay that is already medically complicated.
Reviewers apply criteria that often mirror commercial guidelines such as InterQual and MCG. Those criteria are proprietary and updated on their own schedule. Denial rates vary by plan and by region, and CMS publishes some of that variation through its star ratings and audit findings. A plan with a low denial rate in one state may show a very different pattern in another.
The practical effect is that two patients with similar charts can receive opposite decisions. The difference is often which plan they enrolled in and which vendor reviewed the file.
What Denials Cost Patients
A denied transfer keeps the patient in an acute bed while the appeal proceeds. Hospitals absorb some of that cost, but the enrollee absorbs the rest in copays and in recovery time. Delayed transfers can prolong hospital stays by days, and each additional day carries its own cost-sharing.
Out-of-pocket exposure shifts to families. A skilled nursing stay that is denied becomes a private-pay bill, and private-pay rates for nursing homes run well above the Medicare daily rate. Families who cannot pay often bring the patient home earlier than the clinical team recommends.
Appeals can take weeks. Expedited appeals exist for urgent cases, but the process still requires documentation, phone calls, and sometimes a peer-to-peer review between the discharging physician and the plan's medical reviewer. Some patients forgo skilled nursing entirely rather than fight. A related piece on this site traced how Medicare pays for dialysis while private plans shift it home, and the pattern of shifting site of care while the benefit remains nominally covered is similar.
The financial pressure is not evenly distributed. A patient with savings can pay privately for a few weeks and appeal later. A patient without savings faces a decision within days. That difference in cushion, rather than any difference in clinical need, often determines whether a discharge plan holds together.
Payer Incentives and Programme Design
Capitation rewards reduced utilization. A plan that approves fewer post-acute days retains more of its payment as margin. That is not a secret; it is the design. The counterweight is supposed to be quality measurement, star ratings, and periodic audit by CMS. Star ratings include some appeals and grievance metrics, which gives plans a reason to keep denial rates within a band.
Risk adjustment affects plan payments. Plans receive more for enrollees with documented diagnoses, which creates an incentive to document thoroughly and, critics argue, to code aggressively. The interaction between risk adjustment and utilization management is where a lot of the programme's tension sits.
Oversight relies on periodic audits rather than real-time review. CMS audits examine a sample of denials and can require plans to reprocess them. The audits are retrospective, which means a patient who never appeals may never appear in the data at all.
The honest trade-off is that some utilization review does catch unnecessary care. A plan that approved every long-term acute care admission would face higher premiums for everyone. The question is where the line sits and who bears the cost of drawing it.
Where the Money Goes Instead
Plans retain savings as margin when utilization comes in below the benchmark. Some of that margin goes to administrative costs, some to supplemental benefits like dental or transportation, and some to reserves. The supplemental benefits are real and enrollees value them. They are also funded partly by care that was not delivered.
Home health agencies absorb referrals that would otherwise go to skilled nursing. That can work well for patients with stable home situations. It works badly for patients who live alone or whose homes cannot accommodate equipment. A related piece on this site described how Brazil's free diabetes medicines stop at the border of Amazonas, and the general lesson applies: a benefit that exists on paper can fail at the point of delivery.
LTACH occupancy rates fluctuate with payer policy. When a large plan tightens criteria, referrals drop and beds empty. When criteria loosen, occupancy rises. Consolidation among post-acute providers narrows the options available to a discharging hospital, which can leave families with a single facility that will accept them.
Provider consolidation is not unique to post-acute care. The same dynamics appear in dialysis and home health, where a few large chains negotiate with a few large payers.
The Transparency Gap in Denial Data
One reason the denial problem persists is that the data are incomplete. Plans report some utilization management statistics to CMS, but the categories are broad and the reporting lags. A denial that is overturned on appeal may still be counted as a denial, or it may be reclassified. Researchers and advocates have noted that without patient-level data, it is hard to know whether a plan's denial rate reflects careful review or aggressive cost control.
Medicare Advantage enrollees can request their own claims data, but few do. The volume of paperwork and the lack of a standard format make it difficult for patients to compare their experience with others. Some states have passed laws requiring insurers to report prior authorization data, but those laws often exclude Medicare Advantage, which is federally regulated. The result is a patchwork of information that makes national patterns hard to see.
CMS has taken steps to improve transparency, such as requiring plans to post some prior authorization data. The usefulness of those data depends on how they are structured and how often they are updated. For now, the most detailed information often comes from audits and from the appeals themselves, which means the system learns about problems only after patients have navigated them.
Steps for Patients and Advocates
Request the denial rationale in writing. The letter should state the specific criteria the plan applied and the clinical information it relied on. Without that, an appeal is guesswork.
File an expedited appeal within 72 hours when the situation is urgent. Medicare Advantage plans must respond to expedited requests on a short timeline, though the exact window depends on the plan and the circumstances. Ask the plan to confirm the deadline in writing.
Contact the State Health Insurance Assistance Program for your state. These counsellors are funded to help Medicare enrollees understand appeals and can sometimes intervene directly with a plan.
Ask the discharging hospital for a peer-to-peer review between its physician and the plan's medical reviewer. A clinician-to-clinician call resolves a meaningful share of disputes before they reach a formal appeal.
Document every call, keep copies of every letter, and note the name of each representative. A related piece on this site argued that Kenya's oncology fund covers chemotherapy but not the pathology that guides it, and the same documentation discipline helps anywhere a benefit is administered through review.
This article is informational and is not personalised medical, legal, or financial advice. Coverage rules and appeal timelines vary by plan and by state, and readers should confirm details with their plan, their provider, or a qualified adviser.
